FI45557C - Menetelmä terapeuttisesti arvokkaiden 1,2,4-oksadiatsoli-johdannaisten valmistamiseksi. - Google Patents
Menetelmä terapeuttisesti arvokkaiden 1,2,4-oksadiatsoli-johdannaisten valmistamiseksi.Info
- Publication number
- FI45557C FI45557C FI640509A FI50964A FI45557C FI 45557 C FI45557 C FI 45557C FI 640509 A FI640509 A FI 640509A FI 50964 A FI50964 A FI 50964A FI 45557 C FI45557 C FI 45557C
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- oxadiazole derivatives
- therapeutically valuable
- valuable
- therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Sawing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI000437 | 1963-03-22 | ||
| HUCI000438 | 1963-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI45557B FI45557B (fi) | 1972-04-04 |
| FI45557C true FI45557C (fi) | 1972-07-10 |
Family
ID=26318371
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI632211A FI45977C (fi) | 1963-03-22 | 1963-11-13 | Tapa valmistaa lääkeaineena käytettäviä 3-aralkyyli-5-amiinilla substi tuoituja 1,2,4-oksadiatsoleja. |
| FI640509A FI45557C (fi) | 1963-03-22 | 1964-03-10 | Menetelmä terapeuttisesti arvokkaiden 1,2,4-oksadiatsoli-johdannaisten valmistamiseksi. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI632211A FI45977C (fi) | 1963-03-22 | 1963-11-13 | Tapa valmistaa lääkeaineena käytettäviä 3-aralkyyli-5-amiinilla substi tuoituja 1,2,4-oksadiatsoleja. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US3265692A (fi) |
| BE (2) | BE645478A (fi) |
| BR (2) | BR6457780D0 (fi) |
| CH (3) | CH490409A (fi) |
| CS (2) | CS152413B2 (fi) |
| DE (1) | DE1445603C3 (fi) |
| DK (2) | DK136608B (fi) |
| FI (2) | FI45977C (fi) |
| FR (1) | FR4062M (fi) |
| GB (2) | GB1063323A (fi) |
| NL (3) | NL6402833A (fi) |
| NO (2) | NO115110B (fi) |
| SE (2) | SE319481B (fi) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3458305A (en) * | 1966-08-24 | 1969-07-29 | Gulf Research Development Co | Bispyridinium compounds as herbicides |
| GB1228142A (fi) * | 1967-03-31 | 1971-04-15 | ||
| US3697530A (en) * | 1970-12-31 | 1972-10-10 | Takeda Chemical Industries Ltd | Oxadiazole derivatives |
| DE2860691D1 (en) * | 1977-07-12 | 1981-08-13 | Synthelabo | 1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions |
| DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
| HU180708B (en) * | 1979-10-11 | 1983-04-29 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 1,2,4-oxadiazine derivatives |
| HU190377B (en) * | 1982-03-12 | 1986-08-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing theophyllinyl-alkyl-oxadiazoles |
| IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
| US5066662A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Company | Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors |
| WO2005060961A2 (en) * | 2003-12-18 | 2005-07-07 | Astrazeneca Ab | Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd) |
| JP5167484B2 (ja) * | 2007-05-21 | 2013-03-21 | 日本放送協会 | 撮像装置 |
| WO2012024150A1 (en) * | 2010-08-16 | 2012-02-23 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| JP2013544837A (ja) * | 2010-12-03 | 2013-12-19 | アラーガン インコーポレイテッド | スフィンゴシン−１−リン酸（ｓ１ｐ）受容体モジュレーターとしての新規オキシムアゼチジン誘導体 |
| BR112013013648A2 (pt) | 2010-12-03 | 2016-09-06 | Allergan Inc | derivados de fenil oxadiazol como moduladores de receptor de esfingosina-1-fosfato(s1p) |
| BR112013013640A2 (pt) * | 2010-12-03 | 2016-09-13 | Allergan Inc | derivados de oxima como moduladores de receptores de esfingosina-1-fosfato (s1p) |
| CA2819666A1 (en) | 2010-12-03 | 2012-06-07 | Allergan, Inc. | Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3141019A (en) * | 1964-07-14 | Chaohj |
-
0
- GB GB1053825D patent/GB1053825A/en active Active
- NL NL132134D patent/NL132134C/xx active
- NL NL302339D patent/NL302339A/xx unknown
-
1963
- 1963-11-05 NO NO150693A patent/NO115110B/no unknown
- 1963-11-06 DE DE1445603A patent/DE1445603C3/de not_active Expired
- 1963-11-13 FI FI632211A patent/FI45977C/fi active
- 1963-11-20 CS CS6405A patent/CS152413B2/cs unknown
- 1963-11-28 CH CH634568A patent/CH490409A/de not_active IP Right Cessation
- 1963-11-28 CH CH1456463A patent/CH469731A/de unknown
-
1964
- 1964-01-15 DK DK21464AA patent/DK136608B/da unknown
- 1964-01-20 SE SE659/64A patent/SE319481B/xx unknown
- 1964-03-09 CH CH300564A patent/CH431540A/de unknown
- 1964-03-10 GB GB10059/64A patent/GB1063323A/en not_active Expired
- 1964-03-10 FI FI640509A patent/FI45557C/fi active
- 1964-03-12 DK DK126064AA patent/DK109088C/da active
- 1964-03-17 NL NL6402833A patent/NL6402833A/xx unknown
- 1964-03-19 SE SE03429/64A patent/SE333737B/xx unknown
- 1964-03-19 US US353270A patent/US3265692A/en not_active Expired - Lifetime
- 1964-03-19 NO NO152512A patent/NO118067B/no unknown
- 1964-03-20 BE BE645478D patent/BE645478A/xx unknown
- 1964-03-20 BR BR157780/64A patent/BR6457780D0/pt unknown
- 1964-03-21 CS CS164864A patent/CS154210B2/cs unknown
- 1964-03-24 US US354465A patent/US3280122A/en not_active Expired - Lifetime
- 1964-03-26 FR FR968867A patent/FR4062M/fr not_active Expired
- 1964-03-27 BE BE645822D patent/BE645822A/xx unknown
- 1964-03-30 BR BR157951/64A patent/BR6457951D0/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI45977C (fi) | 1972-11-10 |
| DK136608B (da) | 1977-10-31 |
| BE645822A (fi) | 1964-07-16 |
| GB1063323A (en) | 1967-03-30 |
| DE1445603B2 (de) | 1978-06-15 |
| DE1445620A1 (de) | 1968-12-05 |
| FR4062M (fi) | 1966-04-04 |
| DK109088C (da) | 1968-03-18 |
| US3265692A (en) | 1966-08-09 |
| BE645478A (fi) | 1964-07-16 |
| NL6402833A (fi) | 1964-09-23 |
| SE333737B (fi) | 1971-03-29 |
| FI45977B (fi) | 1972-07-31 |
| CH490409A (de) | 1970-05-15 |
| CH431540A (de) | 1967-03-15 |
| NO118067B (fi) | 1969-11-03 |
| BR6457951D0 (pt) | 1973-04-19 |
| SE319481B (fi) | 1970-01-19 |
| GB1053825A (fi) | |
| NL132134C (fi) | |
| CS152413B2 (fi) | 1973-12-19 |
| DK136608C (fi) | 1978-04-03 |
| DE1445620B2 (de) | 1975-08-07 |
| DE1445603A1 (de) | 1968-12-05 |
| DE1445603C3 (de) | 1979-03-15 |
| NO115110B (fi) | 1968-07-29 |
| BR6457780D0 (pt) | 1973-08-28 |
| US3280122A (en) | 1966-10-18 |
| NL302339A (fi) | |
| CH469731A (de) | 1969-03-15 |
| FI45557B (fi) | 1972-04-04 |
| CS154210B2 (fi) | 1974-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI48590C (fi) | Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi. | |
| FI47364C (fi) | Menetelmä terapeuttisesti arvokkaiden 3-indolyyli-alifaattinen-happoyh disteiden valmistamiseksi. | |
| FI45557C (fi) | Menetelmä terapeuttisesti arvokkaiden 1,2,4-oksadiatsoli-johdannaisten valmistamiseksi. | |
| FI45970C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. | |
| FI49716C (fi) | Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi. | |
| FI46166C (fi) | Menetelmä teknisesti käyttökelpoisten 2,4,6,8,9-penta-atsa-bisyklo-/3. 3.1/-nona-2,6-dieenien valmistamiseksi. | |
| FI45662C (fi) | Menetelmä fysiologisesti arvokkaiden penisilliinien valmistamiseksi. | |
| FI49290C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi. | |
| FI49517C (fi) | Menetelmä terapeuttisesti arvokkaan 2'beta-isopropyyli-5'alfa-n-propyy li-9,10-dihydro-ergopeptiinin valmistamiseksi. | |
| FI45180C (fi) | Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. | |
| FI45041C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi. | |
| FI44622C (fi) | Menetelmä terapeuttisesti arvokkaiden substituoitujen naftaleenijohdan naisten valmistamiseksi. | |
| DK121956B (da) | Analogifremgangsmåde til fremstilling af 1,2,4-oxadiazolderivater. | |
| FI47489C (fi) | Menetelmä tulehduksia ehkäisevien 5-(1-aroyyli-3-indolyyli-metyyli)-te tratsolien valmistamiseksi. | |
| FI47577C (fi) | Tapa valmistaa sepelvaltimoita laajentavan vaikutuksen omaavia 2,4,7-t riamino-6-fenyyli-pteridiinejä. | |
| FI46844C (fi) | Menetelmä 9alfa,21,21-triklooristeroidien valmistamiseksi. | |
| FI44625C (fi) | Menetelmä uusien terapeuttisesti arvokkaiden d-treo-1-fenyyli-2-amino-1,3-propaanidiolijohdannaisten valmistamiseksi | |
| FI46727C (fi) | Menetelmä pyridatsolijohdannaisten valmistamiseksi. | |
| FI47358C (fi) | Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi. | |
| FI44621C (fi) | Menetelmä hypertensiivisten 3,4-dihydroksifenyylipropaani-johdannaiste n valmistamiseksi. | |
| FI46385C (fi) | Menetelmä terapeuttisesti arvokkaiden 1,3-dihydro-3-hydroksi-2H-1,4-be ntsodiatsepiini-2-onijohdannaisten valmistamiseksi. | |
| FI45045C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi. | |
| FI45755C (fi) | Menetelmä 1,2-epoksi-9beta,10alfa-steroidien valmistamiseksi. | |
| FI46724C (fi) | Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi. | |
| FI48732C (fi) | Menetelmä farmakologisesti aktiivisten 3-substituoitu-amino-1,2,3,4-te trahydrokarbatsolien valmistamiseksi. |